The Centres for Medicare and Medicaid Services (CMS) has made some minor changes to its plan to allow Medicare to negotiate some drug prices after a series of lawsuits from disgruntled drugmakers – but has insisted that it remains committed to the programme.The negotiation powers were part of the Inflation Reduction Act (IRA) enacted last […]